(Q31010683)

English

Pharmaceutical development of a parenteral lyophilised formulation of the investigational anticancer agent ES-285.HCl.

scientific article

In more languages
default for all languages
No label defined

No description defined

Statements

Pharmaceutical development of a parenteral lyophilised formulation of the investigational anticancer agent ES-285.HCl (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit